Abstract 763: A phase 1 open-label study to investigate the potential drug-drug interaction (DDI) between single-dose (SD) dacomitinib (PF-00299804; DC) and steady-state (SS) paroxetine (PX) in healthy volunteers (HVs)
Keyword(s):
Phase 1
◽
2014 ◽
Vol 54
(12)
◽
pp. 1407-1420
◽
Keyword(s):
2016 ◽
Vol 42
(2)
◽
pp. 269-279
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 31
(8)
◽
pp. 869-874
◽
Keyword(s):